ANTIBODY CONJUGATES AGAINST PSMA – PHARMACEUTICAL SUBSTANCES AND PHARMACEUTICALS CONTAINING THEM

VN127907APending Publication Date: 2026-08-17JIANGSU HENGRUI MEDICINE CO LTD +1

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: VN1202601439
Authority / Receiving Office: VN · VN
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2023-11-09
Filing Date: 2024-08-02
Publication Date: 2026-08-17

Application Information

Patent Timeline

09 Nov 2023

Priority

02 Aug 2024

Application

VN1202601439

17 Aug 2026

Publication

VN127907A

Inventors: HE, FENG; YE, XIN

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention relates to an anti-PSMA antibody–drug conjugate. Specifically, it is revealed as an anti-PSMA antibody–drug conjugate as expressed by the general formula Pc-LYD, where Pc is the anti-PSMA antibody or its antigen-binding fragment, and L, Y and n are as defined in the description.

Need to check novelty before this filing date? Find Prior Art